Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group-Reference-Cited by-同舟云学术

Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group

Published:2018-01-30 Issue:1 Volume:20 Page:
ISSN:1478-6362
Container-title:Arthritis Research & Therapy
language:en
Short-container-title:Arthritis Res Ther

Author:

Adler Sabine, ,Huscher Dörte,Siegert Elise,Allanore Yannick,Czirják László,DelGaldo Francesco,Denton Christopher P.,Distler Oliver,Frerix Marc,Matucci-Cerinic Marco,Mueller-Ladner Ulf,Tarner Ingo-Helmut,Valentini Gabriele,Walker Ulrich A.,Villiger Peter M.,Riemekasten Gabriela

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13075-018-1517-z.pdf

Reference32 articles.

1. Khanna D, Tseng CH, Farmani N, Steen V, Furst DE, Clements PJ, et al. Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the Scleroderma Lung Study Placebo Group. Arthritis Rheum. 2011;63(10):3078–85.

2. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis. 2007;66(7):940–4.

3. Kowal-Bielecka O, Landewe R, Avouac J, Chwiesko S, Miniati I, Czirjak L, et al. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis. 2009;68(5):620–8.

4. Tashkin DP, Elashoff R, Clements PJ, Roth MD, Furst DE, Silver RM, et al. Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am J Respir Crit Care Med. 2007;176(10):1026–34.

5. Nihtyanova SI, Brough GM, Black CM, Denton CP. Mycophenolate mofetil in diffuse cutaneous systemic sclerosis − -a retrospective analysis. Rheumatology (Oxford). 2007;46(3):442–5.

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases;Arthritis & Rheumatology;2024-07-08

2. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases;Arthritis Care & Research;2024-07-08

3. Effective diagnosis of sacroiliitis in children: evaluating magnetic resonance imaging with the Canadian scoring system;Clinical Rheumatology;2024-05-03

4. Screening value of lung ultrasound and pleural shear wave elastography in connective tissue disease–related interstitial lung disease: a preliminary study;Clinical Rheumatology;2024-05-03

5. The ‘whole landscape’ of research on systemic sclerosis over the past 73 years;Autoimmunity Reviews;2024-05